For example, piperlongumine inhibited TRIM14 signaling by activating the p38/MAPK pathway, thereby enhancing the sensitivity of glioblastoma multiforme to the first-line chemotherapeutic agent temozolomide (92). This evidence concerns the gene TRIM14 and glioblastoma.